Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is April 29, 2024.
All times in Eastern Daylight Time.
-
Poxel fait le point sur sa situation financière au premier trimestre 2024 et annonce le report de la publication de ses résultats annuels 2023LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516) (Paris:POXEL), société biopharmaceutique au stade clinique développant des traitements innovants pour les ... more »
-
Beth Bacall Joins Salem Music NetworkCAMARILLO, Calif.--(BUSINESS WIRE)--Beth Bacall Joins Salem Music Network more »
-
Safeguarding Your Pet: Trupanion Dispels Common Pet Insurance MythsSEATTLE--(BUSINESS WIRE)--With pets holding a special place in our hearts as cherished family members, the need to ensure their well-being has never been more important. However, when faced with un... more »
-
DNB//Back Bay Announces Dates for the Nordic-American Healthcare Conference 2025NEW YORK & BOSTON & OSLO, Norway--(BUSINESS WIRE)--DNB Markets (“DNB”) and Back Bay Life Science Advisors (“Back Bay"), acting through the DNB//Back Bay Healthcare Partnership are pleased to announ... more »
-
Managing Total Cost of Care is a Top Goal but Access to Reliable Data is Challenging, the Latest Trends in Specialty Drug Benefits Report by Pharmaceutical Strategies Group (PSG) FoundDALLAS--(BUSINESS WIRE)--Pharmaceutical Strategies Group (“PSG”), an EPIC company, released its annual Trends in Specialty Drug Benefits Report, co-sponsored by Genentech, a member of the Roche Gro... more »
-
AFYREN : Déclaration des transactions sur actions propresCLERMONT-FERRAND, France & LYON, France--(BUSINESS WIRE)--Regulatory News: AFYREN (Paris:ALAFY), société de greentech qui offre aux industriels des produits biosourcés et bas-carbone grâce à sa tec... more »
-
SMAIO : Mise à disposition du rapport financier annuel 2023LYON, France--(BUSINESS WIRE)--Regulatory News: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, Code ISIN : FR0014005I80 / Mnémonique : ALSMA, éligible PE... more »
-
Poxel Provides a Financial Update for the First Quarter 2024 and Announces the Postponement of its 2023 Full-Year Results ReleaseLYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for chronic seri... more »
-
ADOCIA Announces the Release of Its Universal Registration Document for the Year 2023LYON, France--(BUSINESS WIRE)--Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC) (Paris:ADOC), a clinical-stage biopharmaceutical company focused on the research and development of inno... more »
-
U.S. Air Force Cloud One Selects Rebellion Defense to Strengthen Cyber Resilience of Mission ApplicationsWASHINGTON--(BUSINESS WIRE)--U.S. Air Force's Cloud One program office selects Rebellion Defense to strengthen cyber resilience of mission applications. more »
-
LONDON--(BUSINESS WIRE)-- As Agent Bank, please be advised of the following rate determined on: 4/26/2024 Issue ¦ Westpac Banking Corporation - Series 1518 USD15,000,000 FRN due August 2028 IS... more »
-
ADOCIA annonce la mise à disposition de son Document d’Enregistrement Universel pour l’année 2023LYON, France--(BUSINESS WIRE)--Regulatory News: Adocia (Euronext Paris : FR0011184241 – ADOC) (Paris:ADOC), société biopharmaceutique au stade clinique spécialisée dans la recherche et le développe... more »
-
LONDON--(BUSINESS WIRE)-- As Agent Bank, please be advised of the following rate determined on: 4/29/2024 Issue ¦ National Bank of Canada - Series CBL20 GBP 750,000,000 FRN due May 2026 ISIN N... more »
-
LONDON--(BUSINESS WIRE)-- As Agent Bank, please be advised of the following rate determined on: 4/29/2024 Issue ¦ Sydbank AS - Series 19 EUR 75,000,000 FRN due November 2029 ISIN Number ¦ XS17... more »
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AKRONEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Akero Therapeutics, Inc.... more »